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Abstract 
Background :  To study the outcome of endoscopic 
third ventriculostomy (ETV) 
Methods: In this  observational study an 
endoscopic third ventriculostomy was applied in 
patients who suffered from hydrocephaly. The 
diagnosis of hydrocephalus was determined by 
physical, neurological and neuro-radiological 
criteria. Patients with obstructed hydrocephalus 
whether congenital or acquired, with a dilated 3rd 
ventricle were included. Linear incision was given 
2cm anterior to the coronal suture in mid pupillary 
line. Right frontal burr hole is made. For ETV, burr 
hole is placed on a line joining the foramen of 
monro and inter-peduncular line. Floor of the third 
ventricle was punctured close to or over the dorsum 
sellae. Membrane  was dilated with balloon. Balloon 
was inflated  and subsequently was taken out from 
puncture site. It ensured easy visibility of basilar 
artery and its perforators.   
Result: Age of patients ranged from 06 months to 24 
years, with a mean age of 4 years . Fourteen patients  
had posterior fossa tumour’s with dilated third 
ventricle, sixty four patients had aqua ductal 
stenosis, two patients with CSF ascites as 
complication of ventriculo-peritoneal shunt, eleven 
patients had blocked lower end of ventriculo-
peritoneal shunt. Seven patients had CSF leak.   
Time taken to complete endoscopic third 
ventriculostomy was from 20 to 40 min as compared 
to 1 hour to 1.30 hours, taken in a VP shunt. Patients 
who had ETV performed had a mean hospital stay of 
3 days, where as patients in whom a VP shunt was 
performed stayed in the ward for an average of 5 to 
10 days, depending on how eventful the post op 
period was. The cost incurred to the VP shunt 
patient who remained admitted for an average of 5 
days was between Rupees 16,000 to 25,000, as 
compared to Rs: 2000 for the patient who underwent 
endoscopic third ventriculostomy. 
Conclusion: Patients of  ETV, with less per 
operative time, had decreased length of stay. ETV 
also was less expensive to the patient and he did not 
have to buy the shunt apparatus with less re-
hospitalization rates, compared to patients who had 
undergone shunt.  
Key Words: Endoscopic third ventriculostomy, 
Hydrocephalus, VP shunt  
 
Introduction 
Hydrocephalus is   the accumulation of excess  
cerebrospinal fluid (CSF) in the ventricular system of 
the brain.1  Causes may be obstructive or non 
obstructive in nature. Obstructive causes include 
space-occupying lesions, congenital lesions etc. Non-
obstructive causes include infections, bleeding 
(traumatic/non traumatic).2 The standard treatment is 
inserting a VP shunt, but shunt infections and 
blockage are common problems.3 An alternative to a 
VP shunt is endoscopic third ventriculostomy (ETV). 4 
Long-term extra cranial shunting for hydrocephalus 
can  lead to infections.5, 6 Patients can be managed, 
without significant morbidity, by the use of an 
intracranial cerebrospinal fluid diversion, e.g., third 
ventriculostomy. 7 This method employs endoscope’s 
insertion  through a burr hole, created just anterior to 
the coronal suture. Creation of  a small hole in the 
floor of the 3rd ventricle achieves this.8 First advocated 
by Dandy, ventriculostomy was left in favour of extra 
cranial procedures.9 With improved surgical 
techniques, however, ventriculostomy is now 
considered to be a viable alternative in selected cases.10 
 In patients in whom third ventriculostomy has failed 
and who have required ventriculo-peritoneal shunts, it 
is expected that they will remain less dependent on 
shunts as the hydrocephalus has been converted from 
a non communicating one to a communicating . This  
tends not to have a rapid onset or extreme levels of 
raised intracranial pressure. 11-13 
 For this procedure patients are evaluated clinically 
with progressive head enlargement, tense fontanelle 
with Evan’s ratio 0.7 on CT scan Brain Plain. 14 Tri-
ventricular hydrocephalus is confirmed by CT scan 
brain studies as dilated third ventricle being a 
prerequisite for ETV.15-17 The results indicate that ETV 
is an effective treatment in cases of obstructive 
hydrocephalus,  caused by aqueductal  stenosis and 
space-occupying lesions. 18-20  
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Endoscopic third ventriculostomy (ETV) is  now 
emerging as a first line treatment for non-
communicating hydrocephalus  and in cases with  
shunt failure.21, 22 Due to Improvements in technology, 
endoscopic third ventriculostomy is safer than earlier 
techniques of open third ventriculostomy.23 The 
morbidity and mortality have decreased and the 
effectiveness has also increased. The chance of being 
permanently cured is 80% in favourable cases.24,25 
 
Patients and Methods 
An endoscopic third ventriculostomy was applied in 
88 patients who suffered from hydrocephaly; this was 
done by the department of neurosurgery at District 
Head Quarter Hospital, Rawalpindi from, 31st March 
2014 to 2nd April 2015. Categorical variables studied 
were age, gender, cause of hydrocephalus, 
complications, and evaluated, retrospectively. 
Clinically, most patients frequently presented with 
headache, nausea and vomiting and altered 
consciousness. The diagnosis of hydrocephalus was 
determined by physical, neurological and neuro-
radiological criteria. All patients underwent CT scan of 
the brain (plain) to confirm the diagnosis of 
hydrocephalus. Patients with obstructed 
hydrocephalus whether congenital or acquired, with a 
dilated 3rd ventricle were included. Infants less than 6 
months old, patients having hydrocephalus post 
meningitis, and patients with hydrocephalus 
secondary to sub arachnoid haemorrhage were 
excluded. Patient was given general anaesthesia and  
positioned supine. Head was placed neutral on head 
ring/horse shoe. Linear incision was given 2cm 
anterior to the coronal suture in mid pupillary line. 
Right frontal burr hole was made. For ETV, burr hole 
was placed on a line joining the foramen of Monro and 
inter-peduncular line. After entering the third ventricle 
through the foramen of Monro was identified the 
mamillary bodies,tuber cinerium. Floor of third 
ventricle was punctured close to or over the dorsum 
sellae. In chronic hydrocephalus it was difficult to 
puncture the membrane with the fogarty catheter. 
Membrane can also be punctured with bipolar. After 
puncturing the membrane  was dilated with balloon, 
which was inflated  and subsequently taken out from 
puncture site (Figure 1). It ensured easy visibility of 
basilar artery and its perforators. Outcome of the 
procedure (endoscopic third ventriculostomy) was 
analyzed, with the help of radiological (check CT Scan 
brain plain) and clinical/neurological outcome of the 
patient. 
Results 
Our study included 88 patients who presented with 
hydrocephalus, from March 2014 to April 2015. Fifty 
six patients were male and 32 were females (Age range 
6 months to 24 years).  As their primary pathology to 
perform third ventriculostomy, fourteen patients  had 
posterior fossa tumours with dilated third ventricle, 
sixty one patients  had aqueductal stenosis, two 
patients with CSF ascites as complication of 
ventriculo-peritoneal shunt, Eleven patients  had 
blocked lower end of ventriculo-peritoneal shunt 
(Table 1). CSF leak was the commonest complication . 
Five patients died (Table 2). 
 
Table 1: Indications of third ventriculostomy 
(n=88) 
Diseases Number  Percentage 
Aqueductal stenosis 61 70 
Posterior fossa 
tumours 
14 15 
Blocked VP  shunt 11 13 
CSF Ascites 2 2 
 
 
Figure 1: Completion of the balloon dilation after 
removal of the Fogarty balloon. 
 
Table 2:Complications of Endoscopic third 
ventriculostomy (n=13) 
 
Discussion 
CSF shunting is the mainstay of the treatment of 
hydrocephalus. CSF shunting is associated with 
problems related to under drainage (obstruction, 
disconnection), over- drainage, and infection.1 The 
spectrum of hydrocephalus treatment is drifting 
Complications  Number  Percentage 
CSF leak 7 7.9% 
Chemical meningitis 5 5.7% 
Hypothalamic trauma 3 3.4% 
Intracereberal bleed 7 7.9% 
Wound infection 1 1.1% 
Fits 13 14.9% 
Death 5 5.7% 
Colour 
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towards endoscopic methods instead of shunts. 2 It 
provides a rapid access via small burr holes without 
the need for brain retraction. Cure of hydrocephalus 
cannot be ensured.3 The ventriculostomy is usually 
being made with a blunt instrument such as a guide 
wire, closed forceps, coagulation with monopolar or 
bipolar diathermy, laser fiber, dormia basket, bugbee 
wire or the endoscope itself. Fever and bleeding are 
common complications.4 Short-term memory loss can 
be anticipated, since the procedure may affect the 
hypothalamus and the areas of the mamillary body, 
which are responsible for memory.5 Diabetes insipidus 
is a transient complication.6 Arrhythmias are also 
reported during perforating ventricular floor.7,8,913 
Third ventriculostomy  is considered successful when 
a patient shows improvement in clinical symptoms or 
decrease in ventricular size; and does not require 
placement of a shunt.14,15  In some cases, ventricles 
may remain large, in spite of a return to normal 
intracranial pressure.16-18 Failed procedures can occur 
due to the block in the subarachnoid pathways or 
inability to absorb CSF at arachnoid villi, as in cases 
with tuberculous  meningitis and with thick 
membrane at 3rd ventricular floor.19  
Endoscopic third vetriculostomy (ETV)  can due to 
poor absorption of cerebrospinal fluid (CSF) or  
development of a new or continuing obstruction of 
CSF pathways.20 In infants, ETV failures are due to a 
still poorly developed CSF absorptive capacity.21 
Patterns of endoscopic findings  observed are , 
reclosure of the ventriculostoma, narrowing of the 
ventriculostoma and patent ventriculostoma with new 
arachnoid membranes in the basal cisterns below the 
floor of the third ventricle, not present at the time of 
the first ETV. 22 In all patients, a new obstruction of 
CSF pathways was seen during repeated ETV or shunt 
surgery.23 The presence of preoperative third 
ventricular bowing is predictive of ETV success, with 
nearly a 3-fold likelihood of success compared with 
patients treated with ETV in the absence of such 
bowing. Although bowing is predictive, 33% of 
patients without bowing were also treated successfully 
with ETV. Patients with hydrocephalus often present 
with both intraventricular obstructive and 
communicating components, and determination of the 
predominant component is difficult. Other 
investigators have observed that third ventricular floor 
deformation, or “bowing” of the third ventricular 
floor, is a good indicator of intraventricular obstructive 
hydrocephalus, resulting in higher success rates with 
endoscopic third ventriculostomy (ETV). 24,25 
In present study  rigid endoscope and Fogarty balloon, 
for making third ventriculostomy, was used. In floor 
with tough membrane a bipolar diathermy probe was 
used to achieve the initial perforation, which was then 
enlarged by inflating the balloon of the Fogarty 
catheter. Age less than 6 months, was the strongest 
predictor of a poor ETV out- come, but the cause of 
hydrocephalus and the presence of a prior shunt were 
also found to have predictive value.  
Complications should be kept in mind perioperatively 
by both surgeons and anaesthesiologists, as prompt 
detection and action can help minimize the risks 
associated with neuro-endoscopic procedures. 1,2  
Presence of prepontine arachnoid membranes and the 
use of EVD negatively influenced the chance of 
success. 3 In present study  patients who had any 
previous CSF diversion procedure, were excluded.  
Sankey EW et al 4 analyzed patients with obstructive 
hydrocephalus due to aqueductal stenosis. They  
exhibited symptomatic improvement after ETV, with a 
relatively low failure rate. In our study the aqueductal 
stenosis (70%) was the major indication for the 
endoscopic third ventriculostomy. Waqar M et al 5 
described long-term outcomes of endoscopic third 
ventriculostomy (ETV) in adults with hydrocephalus. 5 
Critical analysis of their study showed that only 
previous shunt was found to influence outcomes (P = 
0.021), with shorter ETV survival noted in patients 
with a previous shunt. while in our study we excluded 
those parients who had any previous CSF diversion 
procedure. 
Conclusion 
1. ETV has less per operative time, decreased length of 
stay. It is less expensive, as the patient does  not to buy 
the shunt .  
1.ETV is a safe procedure with acceptable rates of 
long-term efficacy, however, failure can occur, and 
patients should be instructed to seek medical advice if 
symptoms recur.  
2.A previous shunt is associated with a higher ETV 
failure rate. 
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